To further explore this, breast cancer and malignant melanoma cell lines were treated with the demethylating agent 5-aza-dC and surface expression of HLA-A, HLA-B, HLA-C, HLA-E, HLA-G, and HLA-DR was investigated by flow cytometry. This evidence concerns the gene HLA-B and breast cancer.